Table 2: Complications after TRUSBP according to prophylactic group.
|
Group A (IV Cefoxitin + pocipro) |
Group B (Oral FT) |
p < 0.05 |
Infectious, n (%) |
7 (2.9) |
4 (2.2) |
0.64 |
Prostatitis |
7 (2.9) |
4 (2.2) |
0.64 |
Orchiepididymitis |
0 |
0 |
1.00 |
Sepsis |
4 (1.66) |
0 |
0.14 |
Non-Infectious, n (%) |
16 (6.6) |
9 (4.9) |
0.24 |
Hematuria |
7 (2.9) |
2 (1.09) |
0.31 |
Rectal bleeding |
0 |
1 (0.54) |
0.43 |
Perineal pain |
1 (0.41) |
1 (0.54) |
1.00 |
Acute urinary retention |
3 (1.24) |
5 (2.72) |
0.30 |
Hematospermia |
1 (0.41) |
0 |
1.00 |
Hospitalization |
4 (1.66) |
2 (1.09) |
0.70 |